FORCE advocates for families facing hereditary cancer in areas such as access to care, research funding, insurance and privacy.
Genetic Counseling & Testing
- Florida Enacts Sweeping Genetic Protection Law
- Act Now to Support Broader Access to Genetic Counseling
- Medicare Finalizes Genetic Testing Policy
- BRCA Genetic Screening Recommendations Miss the Mark
- Fraud Alert! Genetic test scams are a growing problem.
- New Legislative Effort Could Wipe Out Laws Preventing Gene Patents
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- FORCE Leads the Charge for Medicaid Coverage of Genetic Testing
- FDA Approves New Direct-to-Consumer Genetic Test for 3 BRCA Mutations
- Clarification Includes Survivors in BRCA Screening Guidelines
- Supreme Court Rules Gene Patents Unlawful
Genetic Privacy & Protection
- Protections against genetic discrimination vs. pre-existing conditions
- Florida Enacts Sweeping Genetic Protection Law
- Fraud Alert! Genetic test scams are a growing problem.
- Lawsuit Targets Wellness Program Penalties and Invasion of Privacy
- Lawsuit Challenges ACA Preexisting Conditions Protections
- Statement Sets the Record Straight on AHCA and HR 1313
- Genetic Information Nondiscrimination Act (GINA)
Hereditary Cancer Awareness
- Florida Enacts Sweeping Genetic Protection Law
- Take Action: Preserve Breast Screenings for Women Ages 40-49
- Act Now to Support Broader Access to Genetic Counseling
- BRCA Genetic Screening Recommendations Miss the Mark
- Fraud Alert! Genetic test scams are a growing problem.
- Statement Sets the Record Straight on AHCA and HR 1313
- EARLY Act Brings Young Breast Cancer to Forefront
- Establishment of National HBOC Week and Previvor Day
Insurance Coverage & Barriers
- Protections against genetic discrimination vs. pre-existing conditions
- FORCE Fights for Our Community, COVID Relief
- Take Action: Preserve Breast Screenings for Women Ages 40-49
- Act Now to Support Broader Access to Genetic Counseling
- Medicare Finalizes Genetic Testing Policy
- BRCA Genetic Screening Recommendations Miss the Mark
- Mammograms for Women Age 40-49 Preserved Until 2020
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- ACA unconstitutional? What does this mean for preventive care and pre-existing conditions?
- New Federal Regulations and Proposals May Hurt High-Risk Cancer Community
- Lawsuit Challenges ACA Preexisting Conditions Protections
- FORCE Supports Chemotherapy Parity Initiatives
- FORCE Leads the Charge for Medicaid Coverage of Genetic Testing
- Ovarian Cancer Screening for High-Risk Women
- Prostate Cancer Screening Guidelines Fall Short
- Clarification Includes Survivors in BRCA Screening Guidelines
- Statement Sets the Record Straight on AHCA and HR 1313
Screening & Prevention
- FORCE Fights for Our Community, COVID Relief
- Take Action: Preserve Breast Screenings for Women Ages 40-49
- FORCE Weighs in on Breast Implant Safety and Informed Consent
- Mammograms for Women Age 40-49 Preserved Until 2020
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- ACA unconstitutional? What does this mean for preventive care and pre-existing conditions?
- Cancer Research Funding Preserved
- Ovarian Cancer Screening for High-Risk Women
- Prostate Cancer Screening Guidelines Fall Short
Device Safety & Drug Development
- FDA Issues New Breast Implant Labeling Recommendations to Improve Patient Communication
- FDA Updates Breast Implant Safety Info, Releases Educational Video
- Medicare Finalizes Genetic Testing Policy
- FORCE Weighs in on Breast Implant Safety and Informed Consent
- New Federal Regulations and Proposals May Hurt High-Risk Cancer Community
- FORCE Supports Chemotherapy Parity Initiatives
- Federal "Right to Try" Legislation Passes, Signed by President
- Cancer Research Funding Preserved
Take Action Now
Public Policy Priorities
News Briefs
10/9/2020 - Endorsed the Senate's version of the CLINICAL TREATMENT Act (S.4742), which would require Medicaid to cover routine care costs for patients with life-threatening conditions participating in clinical trials.
10/5/2020 - Collaborated in submitting comments in support of proposed changes to Medicare's Laboratory Date of Service Rule which will reduce testing and treatment delays for cancer patients.
9/10/2020 - Urged Congress to work toward enactment of the FY21 Defense Appropriations Act, to ensure that the Defense Health Research Programs, including the CDMRP, are fully funded in fiscal year 2021.
8/19/2020 - Joined Medicare stakeholders and advocacy groups in calling for copay assistance for Part D beneficiaries in response to the COVID pandemic pressures.
Sponsored By:
